AU2002222145A1 - Particulate inhalation carrier - Google Patents

Particulate inhalation carrier

Info

Publication number
AU2002222145A1
AU2002222145A1 AU2002222145A AU2214502A AU2002222145A1 AU 2002222145 A1 AU2002222145 A1 AU 2002222145A1 AU 2002222145 A AU2002222145 A AU 2002222145A AU 2214502 A AU2214502 A AU 2214502A AU 2002222145 A1 AU2002222145 A1 AU 2002222145A1
Authority
AU
Australia
Prior art keywords
particulate inhalation
inhalation carrier
carrier
particulate
inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002222145A
Inventor
Dima Al-Hadithi
Stephen Brocchini
Graham Buckton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
School of Pharmacy University of London
Original Assignee
School of Pharmacy University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by School of Pharmacy University of London filed Critical School of Pharmacy University of London
Publication of AU2002222145A1 publication Critical patent/AU2002222145A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002222145A 2000-12-08 2001-12-10 Particulate inhalation carrier Abandoned AU2002222145A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0030074.9A GB0030074D0 (en) 2000-12-08 2000-12-08 Particulate inhalation carrier
GB0030074 2000-12-08
PCT/GB2001/005436 WO2002045682A1 (en) 2000-12-08 2001-12-10 Particulate inhalation carrier

Publications (1)

Publication Number Publication Date
AU2002222145A1 true AU2002222145A1 (en) 2002-06-18

Family

ID=9904780

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002222145A Abandoned AU2002222145A1 (en) 2000-12-08 2001-12-10 Particulate inhalation carrier

Country Status (6)

Country Link
US (1) US20040062719A1 (en)
EP (1) EP1339388A1 (en)
JP (1) JP2004517834A (en)
AU (1) AU2002222145A1 (en)
GB (1) GB0030074D0 (en)
WO (1) WO2002045682A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
JP2005506323A (en) * 2001-09-05 2005-03-03 ベクトゥラ・リミテッド Functional powder for oral delivery
JP2006516531A (en) 2002-08-21 2006-07-06 ノートン ヘルスケアー リミテッド Inhalation composition
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
DE102004048389A1 (en) * 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modification of surfaces of lactose as adjuvant for use with powder inhalants
DE102004048390A1 (en) * 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg New powder inhalants based on modified lactose mixtures as adjuvant
JP4878463B2 (en) * 2005-09-13 2012-02-15 ホソカワミクロン株式会社 Pharmaceutical preparation containing peptide hormone-encapsulated nanoparticles and method for producing the same
DE102006030166A1 (en) * 2006-06-29 2008-01-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg temper
WO2008134817A1 (en) * 2007-05-03 2008-11-13 The University Of Sydney Composite carriers for dry powder inhalation therapy
GB0714134D0 (en) 2007-07-19 2007-08-29 Norton Healthcare Ltd Dry-powder medicament
PL2560611T3 (en) * 2010-04-21 2018-05-30 Chiesi Farmaceutici S.P.A. "process for providing particles with reduced electrostatic charges"
JOP20120023B1 (en) * 2011-02-04 2022-03-14 Novartis Ag Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
RU2696582C2 (en) * 2013-03-15 2019-08-05 Перл Терапьютикс, Инк. Methods and systems for conditioning disperse crystalline materials
PL2821061T3 (en) * 2013-07-01 2018-05-30 Arven Ilac Sanayi Ve Ticaret A.S. Novel inhalation formulations
TN2017000077A1 (en) 2014-09-09 2018-07-04 Vectura Ltd Formulation comprising glycopyrrolate, method and apparatus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5519237A (en) * 1978-07-27 1980-02-09 Toa Iyakuhin Kogyo Kk Crystalline lactose with high beta-lactose content and diluent comprising it
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
JPH11349475A (en) * 1998-06-03 1999-12-21 Dainippon Pharmaceut Co Ltd Intraoral disintegrant and its production

Also Published As

Publication number Publication date
EP1339388A1 (en) 2003-09-03
JP2004517834A (en) 2004-06-17
GB0030074D0 (en) 2001-01-24
US20040062719A1 (en) 2004-04-01
WO2002045682A1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
SG123530A1 (en) Disk carrier
AU2001284668A1 (en) Carrier tape
AU2002211949A1 (en) Particulate trap
AU2002223028A1 (en) Inhaler
AU2001246542A1 (en) Catalyst constituent
AU2001272815A1 (en) Baby carrier
AU2002222145A1 (en) Particulate inhalation carrier
AU2001268750A1 (en) Flushed-seal respirator
AU6847300A (en) Exhaust volume
AU2001261562A1 (en) Magnetic carrier particles
AU2001276511A1 (en) Respirators
GB0020616D0 (en) Particulates
AU2002322834A1 (en) Disk carrier
AU2001259756A1 (en) Magnetic carrier particles
AU2343901A (en) Baby carrier
AU2001269744A1 (en) Rivet carrier
AU2001294274A1 (en) Antibody inhibiting VPLF activity
AU2001238089A1 (en) Particulate distributor
AU2001262014A1 (en) Baby carrier
PL111932U1 (en) Hand carrier
AU6857200A (en) Parallel rule
AU2000279670A1 (en) Bind carrier
GB0117453D0 (en) Carrier
AUPQ699600A0 (en) Carrier
AU2001278854A1 (en) Pet carrier